Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (31)

2024

  1. β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia–reperfusion injury

    Basic Research in Cardiology, Vol. 119, Núm. 5, pp. 773-794

2023

  1. MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM)

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics

    Basic Research in Cardiology, Vol. 117, Núm. 1

2021

  1. Sustained elevated blood pressure accelerates atherosclerosis development in a preclinical model of disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

2020

  1. Successful aging: Insights from proteome analyses of healthy centenarians

    Aging, Vol. 12, Núm. 4, pp. 3502-3515

  2. The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Cardiomyocyte- and not endothelial-specific (β3-adrenergic receptor stimulation protects the heart against ischemia/reperfusion injury (Póster)

    Journal of the American College of Cardiology, Vol. 71, Núm. 11 suplemento, pp. A8

  2. Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318

  3. Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model

    Journal of Physiology, Vol. 596, Núm. 6, pp. 1035-1061

2017

  1. Circulating leptin and adiponectin concentrations in healthy exceptional longevity

    Mechanisms of Ageing and Development, Vol. 162, pp. 129-132

  2. Neutrophil stunning by metoprolol reduces infarct size

    Nature Communications, Vol. 8

2016

  1. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

    Basic Research in Cardiology, Vol. 111, Núm. 4

  2. Biological rationale for regular physical exercise as an effective intervention for the prevention and treatment of depressive disorders

    Current Pharmaceutical Design, Vol. 22, Núm. 24, pp. 3764-3775

  3. Endurance Exercise and the Heart: Friend or Foe?

    Sports Medicine

  4. IPSCs-based anti-aging therapies: Recent discoveries and future challenges

    Ageing Research Reviews, Vol. 27, pp. 37-41

  5. No evidence of adverse cardiac remodeling in former elite endurance athletes

    International Journal of Cardiology, Vol. 222, pp. 171-177

  6. ‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue

    Journal of Physiology, Vol. 594, Núm. 12, pp. 3187-3207

2015

  1. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2

    Journal of the American College of Cardiology, Vol. 65, Núm. 14, pp. 1438-1450

  2. Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: New insights from a comprehensive translational study

    Journal of the American Heart Association, Vol. 4, Núm. 1

  3. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 35, Núm. 1, pp. 50-59